S
Steven E. Lipshultz
Researcher at University at Buffalo
Publications - 514
Citations - 65630
Steven E. Lipshultz is an academic researcher from University at Buffalo. The author has contributed to research in topics: Cardiomyopathy & Cardiotoxicity. The author has an hindex of 102, co-authored 505 publications receiving 57200 citations. Previous affiliations of Steven E. Lipshultz include Roswell Park Cancer Institute & National Institutes of Health.
Papers
More filters
Journal ArticleDOI
Associations between neurohormonal and inflammatory activation and heart failure in children
TL;DR: Neuroendocrine and inflammatory activation are associated with more severe symptoms and worse cardiac characteristics in pediatric HF, and blood levels of these biomarkers could be used to better assess the severity of HF in children.
Journal ArticleDOI
Maternal and infant factors associated with failure to thrive in children with vertically transmitted human immunodeficiency virus-1 infection: the prospective, P2C2 human immunodeficiency virus multicenter study.
Tracie L. Miller,Kirk A. Easley,Weihong Zhang,E. John Orav,Dennis M. Bier,Elisabeth Luder,Andrew Ting,William T. Shearer,Jorge Vargas,Steven E. Lipshultz +9 more
TL;DR: Clinical and laboratory factors associated with FTT among HIV-1-infected children include history of pneumonia, maternal illicit drug use during pregnancy, lower infant CD4+ T-cell count, exposure to antiretroviral therapy by 3 months of age (non-protease inhibitor), and HIV- 1 RNA viral load.
Journal ArticleDOI
A Multifaceted Evaluation of Imatinib-induced Cardiotoxicity in the Rat
Eugene H. Herman,Alan Knapton,Elliot T. Rosen,Karol L. Thompson,Barry A. Rosenzweig,Joel Estis,Sara J. Agee,Quynh Anh Lu,John Todd,Steven E. Lipshultz,Brian B. Hasinoff,Jun Zhang +11 more
TL;DR: The authors conclude that Imb exerts cardiotoxic effects that are manifest through a complex pattern of cellular alterations, the severity of which can be influenced by arterial blood pressure.
Journal ArticleDOI
Expected and Actual Case Ascertainment and Treatment Rates for Children Infected with Hepatitis C in Florida and the United States: Epidemiologic Evidence from Statewide and Nationwide Surveys
Aymin Delgado-Borrego,Aymin Delgado-Borrego,Lesley J. Smith,Maureen M. Jonas,Cyndena A. Hall,Betania Negre,Sergio H. Jordan,Matthew Ogrodowicz,Roshan Raza,David A. Ludwig,Tracie L. Miller,Steven E. Lipshultz,Regino P. Gonzalez-Peralta,Raymond T. Chung +13 more
TL;DR: The identification of children infected with HCV in the nation as a whole is grossly inadequate and in Florida, less than 2% of children identified receive treatment, and in the United States, only 4.9% of the expected cases have been identified.
Journal ArticleDOI
A translational approach to detecting drug-induced cardiac injury with cardiac troponins: consensus and recommendations from the Cardiac Troponins Biomarker Working Group of the Health and Environmental Sciences Institute.
Brian R. Berridge,Syril Pettit,Dana Walker,A.S. Jaffe,Albert E. Schultze,Eugene H. Herman,William J. Reagan,Steven E. Lipshultz,Fred S. Apple,Malcolm York +9 more
TL;DR: Results of a workshop sponsored by the Cardiac Troponin Biomarker Working Group included consensus statements, recommendations for further research, and a proposal for a cross-disciplinary group of clinical, regulatory, and drug development scientists to collaborate in such research.